PALATIN TECHNOLOGIES, INC. Marketable Securities, Unrealized Gain (Loss), Excluding Other-than-temporary Impairment Loss
PALATIN TECHNOLOGIES, INC. (PTN) reported Marketable Securities, Unrealized Gain (Loss), Excluding Other-than-temporary Impairment Loss of $590 for the 12-month period ending 2018-06-30, per its 10-K filed 2020-09-25.
Discontinued › Income Statement › Other Income
us-gaap:MarketableSecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairments · last filed 2020-09-25
- PALATIN TECHNOLOGIES, INC. marketable securities, unrealized gain (loss), excluding other-than-temporary impairment loss for the quarter ending 2018-06-30 was $0.00.
- PALATIN TECHNOLOGIES, INC. marketable securities, unrealized gain (loss), excluding other-than-temporary impairment loss for the quarter ending 2018-03-31 was $0.00.
- PALATIN TECHNOLOGIES, INC. marketable securities, unrealized gain (loss), excluding other-than-temporary impairment loss for the quarter ending 2017-12-31 was $153.00.
- PALATIN TECHNOLOGIES, INC. marketable securities, unrealized gain (loss), excluding other-than-temporary impairment loss for the quarter ending 2017-09-30 was $437.00.
- PALATIN TECHNOLOGIES, INC. marketable securities, unrealized gain (loss), excluding other-than-temporary impairment loss for fiscal 2018 was $590.00, a 56.43% decline from fiscal 2017.
- PALATIN TECHNOLOGIES, INC. marketable securities, unrealized gain (loss), excluding other-than-temporary impairment loss for fiscal 2017 was $1.35K.
- PALATIN TECHNOLOGIES, INC. marketable securities, unrealized gain (loss), excluding other-than-temporary impairment loss for fiscal 2016 was -$1.94K.
- PALATIN TECHNOLOGIES, INC. marketable securities, unrealized gain (loss), excluding other-than-temporary impairment loss for fiscal 2011 was -$19.30K, a 185.65% decline from fiscal 2010.
| Period end | Marketable Securities, Unrealized Gain (Loss), Excluding Other-than-temporary Impairment Loss 3 month | Marketable Securities, Unrealized Gain (Loss), Excluding Other-than-temporary Impairment Loss 6 month | Marketable Securities, Unrealized Gain (Loss), Excluding Other-than-temporary Impairment Loss 9 month | Marketable Securities, Unrealized Gain (Loss), Excluding Other-than-temporary Impairment Loss 12 month |
|---|---|---|---|---|
| 2018-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-09-25 | $0.00 derived: sum of 2 quarters · filed 2020-09-25 | $153.00 derived: sum of 3 quarters · filed 2020-09-25 | $590.00 10-K · filed 2020-09-25 |
| 2018-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-05-09 | $153.00 derived: sum of 2 quarters · filed 2019-05-09 | $590.00 10-Q · filed 2019-05-09 | |
| 2017-12-31 | $153.00 10-Q · filed 2019-02-11 | $590.00 10-Q · filed 2019-02-11 | ||
| 2017-09-30 | $437.00 10-Q · filed 2018-11-09 | |||
| 2017-06-30 | $1.35K 10-K · filed 2019-09-12 | |||
| 2016-06-30 | -$1.94K 10-K · filed 2018-09-13 | |||
| 2011-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-09-27 | -$9.78K derived: sum of 2 quarters · filed 2013-09-27 | -$29.31K derived: sum of 3 quarters · filed 2013-09-27 | -$19.30K 10-K · filed 2013-09-27 |
| 2011-03-31 | -$9.78K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-05-14 | -$29.31K derived: sum of 2 quarters · filed 2012-05-14 | -$19.30K 10-Q · filed 2012-05-14 | |
| 2010-12-31 | -$19.53K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-02-14 | -$9.52K 10-Q · filed 2012-02-14 | ||
| 2010-09-30 | $10.01K 10-Q · filed 2011-11-14 | |||
| 2010-06-30 | $22.54K 10-K · filed 2012-09-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B |